Downregulation of hexokinase 2 improves radiosensitivity of breast cancer

BACKGROUND: Hexokinase 2 (HK2) is a major glycolytic enzyme that plays a critical role in the development of tumor metabolism. Triple negative breast cancers (TNBC) have high glycolytic activity and poor prognosis. This study explored the effect of HK2 on radiotherapy (RT) sensitivity of TNBC. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dan, Wang, Hui, Yu, Wenjing, Qiao, Feng, Su, Xiaoyu, Xu, Huiqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798562/
https://www.ncbi.nlm.nih.gov/pubmed/35116758
http://dx.doi.org/10.21037/tcr.2019.01.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798562/
https://www.ncbi.nlm.nih.gov/pubmed/35116758
http://dx.doi.org/10.21037/tcr.2019.01.37

Ejemplares similares